RF1 had a 12.1% net performance over the last 12 months compared to ASX300 (11.58%) and ASX Small Ordinaries (7.8%) despite this supposed defensive positioning and <100% net exposure.
- Forums
- ASX - By Stock
- RF1
- Ann: RF1 Dec23 Distribution Estimate Additional Information
Ann: RF1 Dec23 Distribution Estimate Additional Information, page-8
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RF1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.58 |
Change
0.000(0.00%) |
Mkt cap ! $666.9M |
Open | High | Low | Value | Volume |
$3.60 | $3.65 | $3.58 | $475.3K | 131.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 23364 | $3.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.63 | 3364 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 23364 | 3.570 |
2 | 6469 | 3.560 |
3 | 24106 | 3.510 |
7 | 23000 | 3.500 |
2 | 6900 | 3.490 |
Price($) | Vol. | No. |
---|---|---|
3.630 | 3364 | 2 |
3.640 | 26163 | 2 |
3.650 | 13408 | 3 |
3.660 | 10000 | 1 |
3.700 | 18000 | 1 |
Last trade - 15.52pm 12/11/2024 (20 minute delay) ? |
Featured News
RF1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online